Tilray | TRLY - 净收入

金融业

USD 4.28

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 3.39B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	净收入	更改		日
Acasti Pharma	USD -938K		2.42M	2025-09
Akebia Therapeutics	USD -12.24M		12.78M	2025-12
Alaunos Therapeutics	USD -1.01M		153K	2026-03
Aurora Cannabis	CAD -71.1M		72.92M	2026-03
Avita Medical	AUD -11.62M		1.7M	2025-12
Canopy Growth	CAD -157.11M		94.49M	2026-03
Cronos Group	USD 32.08M		18.33M	2026-06
Dianthus Therapeutics	USD -40.83M		23.6M	2026-03
Divis Laboratories Ltd	INR 9.02B		1.51B	2026-06
Ionis Pharmaceuticals	USD -114.65M		21.65M	2026-06
IQVIA Holdings	USD 256M		18M	2026-06
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Moderna	USD -1.34B		517M	2026-03
Organigram Holdings	CAD -921K		20.89M	2026-03
Organon & Co	USD 108M		38M	2026-06
Revvity	USD 51.82M		11.1M	2026-06
Tectonic Therapeutic	USD -25.24M		6.02M	2026-03
Tilray	USD -44.93M		44.61M	2025-09
Viatris	USD -118.8M		295.2M	2026-06
Xeris Pharmaceuticals	USD 2.23M		8.85M	2026-03
Zealand Pharma A/S	-394M		14.88M	2026-03